NCT01487239

Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0980 Following Single Oral Dose Administration in Healthy Postmenopausal Female Subjects

A Phase I Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0980 Following Single Oral Dose Administration in Healthy Postmenopausal Female Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 4 (actual)
• Sponsor: Genentech, Inc. · Industry
• Sex: Female
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

This study will be an open-label, non-randomized, absorption, metabolism, and excretion study of \[14C\]-GDC-0980 administered as a 10-mg oral dose to 6 healthy postmenopausal and/or surgically sterile female subjects following at least a 10-hour fast from food (not including water).

Conditions

• Healthy Volunteer

Interventions

Type	Name	Description
DRUG	[14C]-GDC-0980	100 uCi of \[14C\]-GDC-0980 in total dose of 10 mg GDC-0980

Timeline

• Start date: 2011-12-01
• Primary completion: 2012-01-01
• Completion: 2012-01-01
• First posted: 2011-12-07
• Last updated: 2016-11-02

Locations

1 site across 1 country: United States